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ABSTRACT 24 
 Resistance to gastrointestinal conditions is a requirement for bacteria to be 25 
considered probiotics. In this work, we tested the resistance of six different Lactobacillus 26 
strains and the effect of carbon source to four different gastrointestinal conditions: presence 27 
of α-amylase, pancreatin, bile extract and low pH. Novel galactooligosaccharides 28 
synthesized from lactulose (GOS-Lu) as well as commercial galactooligosaccharides 29 
synthesized from lactose (GOS-La) and lactulose were used as carbon sources and 30 
compared with glucose. In general, all strains grew in all carbon sources, although after 24 31 
h of fermentation the population of all Lactobacillus strains was higher for both types of 32 
GOS than for glucose and lactulose. No differences were found among GOS-Lu and GOS-33 
La. α-amylase and pancreatin resistance was retained at all times for all strains. However, a 34 
dependence on carbon source and Lactobacillus strain was observed for bile extract and 35 
low pH resistance. High hydrophobicity was found for all strains with GOS-Lu when 36 
compared with other carbon sources. However, concentrations of lactic and acetic acid 37 
were higher in glucose and lactulose than GOS-Lu and GOS-La. These results show that 38 
the resistance to gastrointestinal conditions and hydrophobicity is directly related with the 39 
carbon source and Lactobacillus strains. In this sense, the use of prebiotics as GOS and 40 
lactulose could be an excellent alternative to monosaccharides to support growth of 41 
probiotic Lactobacillus strains and improve their survival through the gastrointestinal tract.  42 
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1. INTRODUCTION 46 
 Probiotics are live microorganisms (mainly lactobacillus and bifidobacteria) which 47 
administered in adequate amounts confer a health benefit to the host (FAO/WHO, 2003).  48 
The Lactobacillus genus is distributed in various ecological niches and is an important 49 
constituent of the human and animal gut microbiota (Charteris et al., 1997).  50 
 Lactobacilli are currently added to a variety of functional foods and several studies 51 
have demonstrated their beneficial properties in human health (Reid et al., 2011). However, 52 
an important requirement is that these bacteria should be able to survive gastrointestinal 53 
conditions (amylases in the oral cavity, low pH in the stomach, bile secretions and 54 
pancreatic juice in the duodenal section of the small intestine). Several in vivo (Jain et al., 55 
2004; Reid, 2008; Park et al., 2008) and in vitro (Charteris et al., 1998; Fernandez et al., 56 
2003; Pitino et al., 2010)  studies have indicated that some Lactobacillus strains only 57 
partially survive the passage through gastrointestinal tract and it is said that generally a 58 
population of 10
7
 – 109 CFU per mL of bacterial cells should be present in foods in order to 59 
colonize, at least temporally, the intestine (Lee & Salminen, 1995). Nevertheless, it has 60 
been observed that only specific strains can survive these conditions. In this sense, 61 
Fernández et al. (2003) reported that L. acidophilus and L. gasseri strains were resistant to 62 
low pH and to the presence of different gastrointestinal enzymes. Similarly, Pitino et al. 63 
(2010) observed that six different strains of L. rhamnosus were resistant to a simulated 64 
human digestion process and Charteris et al. (1998) studied the survival of seven different 65 
Lactobacillus species where L. fermentum KLD was considered intrinsically resistant; 66 
additionally, these authors found that the addition of milk protein improved the tolerance of 67 
the probiotics to gastrointestinal conditions. Similar results have been found by Chavarri et 68 
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al. (2010) and Madureira et al. (2010) using microencapsulation with alginate-chitosan and 69 
whey cheese matrix, respectively. 70 
 Kimoto-Nira et al. (2010) have recently studied the resistance of Lactococcus lactis 71 
G50 grown in six different non-prebiotic carbohydrates (fructose, glucose, galactose, 72 
xylose, lactose and sucrose) under simulated gastrointestinal stress. The survival behaviour 73 
of G50 strain was found to be dependent on the carbon source where they were grown. 74 
However, to the best of our knowledge the resistance to gastrointestinal conditions of 75 
Lactobacillus strains grown in prebiotic carbohydrates has rarely been considered. Valerio 76 
et al. (2006) reported the protective effect of artichokes on different probiotics strains in the 77 
gastrointestinal tract could be hypothetically attributed to the presence of prebiotic 78 
carbohydrates and to the physical structure of the vegetable matrix. 79 
  Prebiotics are defined as “nondigestible food ingredients that beneficially affects 80 
host by selectively stimulating the growth and/or activity of one or a limited number of 81 
bacteria in the colon” (Gibson et al., 2004). Some prebiotic carbohydrates are currently 82 
available in the market, such as fructooligosaccharides, lactulose, inulin and 83 
galactooligosaccharides from lactose (GOS-La) (Rastall, 2010). However, currently there is 84 
considerable interest in the discovery of new carbohydrates with potential prebiotic 85 
properties. Among them, galactooligosaccharides from lactulose (GOS-Lu) have recently 86 
been studied (Cardelle-Cobas et al., 2008; Martinez-Villaluenga et al., 2008). GOS-Lu can 87 
be obtained by transgalactosylation reaction of the lactulose by the action of β-88 
galactosidases from different bacterial sources (Cardelle-Cobas et al., 2008; Martinez-89 
Villaluenga et al., 2008). Recently, it has been reported that GOS-Lu have the ability to 90 
promote the growth of bifidobacteria using in vitro fermentation systems with human fecal 91 
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cultures in a similar manner as the more highly recognised prebiotic GOS-La (Cardelle-92 
Cobas et al., 2009). 93 
Therefore, the aim of this study was to investigate the growth of six Lactobacillus 94 
strains, normally used in fermented food, with different prebiotics (lactulose, GOS from 95 
lactose and GOS from lactulose) as carbon sources and to determine their resistance to 96 
different gastrointestinal conditions (amylases, low pH, bile extract and pancreatin). 97 
Hydrophobicity as a measure of potential adhesion of lactobacillus, as well as lactic and 98 
acetic acid concentrations produced during incubation were also evaluated.  99 
 100 
2. MATERIALS AND METHODS 101 
2.1.Chemicals 102 
 Glucose, lactulose, bile extract, pancreatin and α-amylase (1440 units/mg protein) 103 
from porcine pancreas, β-galactosidase from Aspargillus oryzae (8.0 units/mg protein) and 104 
n-hexadecane was purchased from Sigma-Aldrich (St. Louis, USA). The bacteriological 105 
growth media supplements were obtained from EMD Chemicals, Gibbstown, NJ. The 106 
galactooligosaccharide from lactose (GOS-La) was obtained from Vivinal-GOS
®
, kindly 107 
provided by Friesland Foods Domo (Zwolle, The Netherlands). This product has a 73 wt% 108 
dry matter, the composition of which was 60 wt% GOS, 20 wt% lactose, 19 wt% glucose 109 
and 1 wt% galactose, as stated by the supplier. Duphalac
®
 (Solvay Pharma, Brussels, 110 
Belgium) was used to obtain the galactooligosaccharides from lactulose (GOS-Lu). 111 
 112 
2.2.Preparation of galactooligosaccharides  113 
 In order to purify the GOS-La, the industrial product Vivinal-GOS
®
 was 114 
fractionated using size exclusion chromatography, following the method reported by 115 
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Hernandez et al. (2009) with some modifications. In brief, 80 mL of Vivinal-GOS
®
 (25 % 116 
w/v) were injected in a Bio-Gel P2 (Bio-Rad Hercules, CA, USA) column (90 x 5 cm) 117 
using water as mobile phases, at 1.5 mL min
-1
. Sixty fractions of 10 mL were collected, 118 
after the elution of void volume. The fractions degree polymerization (DP) was determined 119 
by electrospray ionization mass spectrometry (ESI-MS) at positive mode, ranging from 120 
monosaccharides to octasaccharides. Fractions with DP ≥ 3 were pooled and freeze dried.  121 
GOS from lactulose were obtained following the method previously described 122 
(Clemente et al., 2011). A solution (450 g L
-1
) of lactulose (Duphalac
®
) was dissolved in 50 123 
mM sodium phosphate buffer and 1 mM MgCl2, pH 6.5, after addition of 8 U mL
-1
 of β-124 
galactosidase from Aspergillus oryzae (Sigma, St. Louis, MO USA), and incubation at 50 125 
ºC for 20 h under continuous agitation at 300 rpm. After incubation, the mixtures were 126 
immediately immersed in boiling water for 5 min to inactivate the enzymes. The DP of 127 
initial GOS-Lu mixture contained from monosaccharides to octasaccharides. Subsequently, 128 
the GOS-Lu mixture was fractionated using size exclusion chromatography in order to 129 
remove mono- and disaccharides, following the previous methodology applied to Vivinal-130 
GOS
®
.  131 
 132 
2.3.Bacterial Strains  133 
Lactobacillus bulgaricus ATCC7517 (LB), Lactobacillus casei ATCC11578 (LC), 134 
Lactobacillus delbrueckii subsp. lactis ATCC4797 (LD), Lactobacillus plantarum 135 
ATCC8014 (LP1), Lactobacillus plantarum WCFS1 (LP2) and Lactobacillus sakei 23K 136 
(LS) were purchased in lyophilized form and maintained at -80 ºC for long-term storage. 137 
All these strains are considered as probiotics as previously reported previously in different 138 
studies (Jain et al., 2004; Reid, 2008; Park et al., 2008). 139 
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Freeze-dried strains were grown in Lactobacilli MRS broth or in Lactobacilli MRS 140 
agar (EMD Chemicals, Gibbstown, NJ) at 37 °C in an anaerobic chamber (10% CO2: 5% 141 
H2: 85% N2) (Coy Laboratory Products, Ann Arbor, MI) after transfer through an airlock 142 
with two exchanges of N2 gas followed by one exchange of the oxygen-free mixed gas of 143 
the same composition as within the chamber. 144 
 145 
2.4.Growth conditions 146 
 Bacteria were grown in MRS basal media carbohydrate free containing: 10 g L
-1
 147 
protease peptone, 10 g L
-1
 beef extract, 5 g L
-1
 yeast extract, 1 g L
-1
 Tween 80, 2 g L
-1
 148 
ammonium citrate, 5 g L
-1
 sodium acetate, 0.1 g L
-1 
magnesium sulphate, 0.05 g L
-1 
 149 
manganese sulphate, 2 g L
-1 
dipotassium sulphate and 0.5 g L
-1 
cysteine-HCl. Glucose, 150 
lactulose, GOS-La and GOS-Lu were dissolved in water (10 % w/v) and sterilized by 151 
filtration, this solution was added to MRS basal media to a final concentration of 1% w/v. 152 
The incubation was carried out under anaerobic conditions at 37 ºC. Inoculum was prepared 153 
from 48 h MRS grown Lactobacillus cells and approximately 1 x 10
7
 CFU per mL of each 154 
Lactobacillus strain (individually) was added to the MRS basal media containing 1% w/v 155 
of glucose, lactulose, GOS-La or GOS-Lu and incubated under anaerobic conditions, at 156 
37ºC during 24, 48, 72 and 120 hours. Viable count was carried out by plating on MRS 157 
agar in duplicate.  All experiments were carried out in triplicate. 158 
 159 
2.5.Lactic and acetic acid analyses 160 
The incubated samples at 24, 48, and 72 h were centrifuged at 13,000 g for 10 min 161 
to remove all insoluble particles and the lactic and acetic acid fermentation products were 162 
quantified using a BioRad HPX-87H HPLC column (Watford, UK) at 50 ºC, with a 0.005 163 
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mM H2SO4 as the mobile phase, in isocratic mode, at a flow rate of 0.6 mL min
-1
 (Sanz et 164 
al., 2005). The analyses were carried out in triplicate. 165 
Since minor levels of acetic acid were initially present in the MRS broth, this value 166 
was quantified and subtracted from the amounts calculated for the samples subjected to 167 
incubation. 168 
 169 
2.6.Tolerance to different gastrointestinal conditions 170 
One mL aliquots of cultures was taken after 48 h of fermentation as outlined 171 
previously and then centrifuged for 15 min, at 4 ºC and 8,000 rpm. The cells were washed 172 
twice using PBS buffer. The cell pellet was re-suspended in 1 mL of PBS pH 7.0 with: (i) 173 
bile extract (0.3 % w/v), or (ii) α-amylase (100 U mL-1) or (iii) pancreatin (0.2 % w/v; a 174 
mixture of digestive enzyme secreted by the pancreas and commonly used to simulate the 175 
pancreatic juice present in the intestinal digestion), or (iv) 1 mL of saline solution adjusting 176 
the pH with HCl 0.1 M (0.85 % w/v; pH 2.5) for low pH studies. The percentage of 177 
survival was calculated from triplicate experiments using the following formula: 178 
% survival = (β / α) * 100 179 
Where α is the CFU per mL of the assayed strain at 48 h and β the CFU per mL of 180 
the same strain after incubation with the different gastrointestinal conditions.   181 
 182 
2.7.Hydrophobicity of bacteria 183 
 Hydrophobicity was determined following the method proposed by Kimoto-Nira et 184 
al. (2010) with some modifications. After 48 h of incubation the bacteria grown on the 185 
different substrates (glucose, lactulose, GOS-La and GOS-Lu) were washed and suspended 186 
in PBS in order to obtain an OD620 of 1.0. One millilitre of n-hexadecane was added to 1.0 187 
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mL of cell suspensions. The solution was incubated during 10 min at 30ºC, mixed during 188 
60 s and then left to stand for 15 min. The aqueous phase was removed and the OD620 189 
determined. The percentage of hydrophobicity was calculated using the following equation: 190 
100 x [1-(Initial OD620/OD620 after incubation with n-hexadecane]. The analyses were 191 
carried out by triplicate. 192 
  193 
2.8.Statistical analyses 194 
Statistical analyses were performed using Statistica for Windows version 6 (2002) 195 
by Statsoft Inc. (Tulsa, OK, USA). Differences between bacterial survival, % of 196 
hydrophobicity and lactic and acetic acid concentrations were tested using one-way 197 
ANOVA test, followed by a least significant difference (LSD) test as a post hoc 198 
comparison of means (P<0.05).   199 
200 
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3. RESULTS AND DISCUSSION 201 
 202 
3.1.Growth of Lactobacillus strains with prebiotic sources 203 
The growth profiles of six different Lactobacillus strains in the presence of 204 
lactulose, GOS-La, GOS-Lu are shown in Figure 1. Glucose was also included in this study 205 
for comparative purposes. All Lactobacillus strains grew during the first 24 h for all the 206 
substrates. Higher growth rates were observed for LC and LD with glucose and lactulose 207 
than with GOS-La and GOS-Lu substrates, whereas for LP1, LP2 and LS the initial growth 208 
rates were similar for all carbohydrates tested, and for LB the lowest initial growth was 209 
obtained with glucose. However, after this time, growth rates of all Lactobacillus strains 210 
decreased quickly when they were grown with glucose and lactulose, whilst all strains kept 211 
constant or were slightly modified with GOS-Lu and GOS-La. This response could be 212 
attributed to different reasons. It is known that carbohydrates with longer chain lengths are 213 
fermented more slowly (Cummings et al., 2001) which is in agreement with the 214 
fermentation kinetics of lactobacillus strains exhibited in presence of GOS-La and GOS-Lu 215 
(Figure 1). Likewise, this could also explain the initial higher growth observed for LC and 216 
LD with glucose and lactulose at 24 hours of incubation. However, no notable differences 217 
were detected between GOS-La and GOS-Lu for all fermentation times and strains. Similar 218 
behaviour has previously been reported in some bifidobacteria species, using 219 
fructooligosaccharides and inulin as the carbon sources, where the oligomers with high 220 
molecular weight promoted a higher bacterial growth than other substrates with lower 221 
molecular weight (Vernazza et al., 2006). 222 
Conversely the metabolism of large carbohydrate molecules requires the use of 223 
glycosidases and specific transport mechanisms for the hydrolysis products (Vernazza et 224 
 11 
al., 2006). In Lactobacillus genus, the β-galactosidases are specifically located in the 225 
cytoplasm (Fortina et al., 2003) which implies that for the metabolization of GOS, 226 
Lactobacillus strains need a transport system in order to hydrolyze these oligosaccharides 227 
into the cell by β-galactosidases. This could explain the slower growth of LC and LD 228 
strains at 24 h with GOS-Lu and GOS-La compared with glucose and lactulose; however, 229 
for LP1, LP2 and LS, the similar values for initial growth provide evidence for a strain-230 
dependence on the assimilation of carbon source.    231 
Furthermore, it has been previously observed that the monomeric composition, 232 
polymerization degree and type of glycosidic linkages can affect the growth of probiotic 233 
strains (Rastall et al., 2005). GOS-La obtained from Vivinal-GOS
®
 primarily consist of  β-234 
(1-4) linkages (Coulier et al. 2009; Rastall, 2010) and GOS-Lu consist of β-(1-6), being the 235 
most abundant trisaccharide 6´-galactosyl-lactulose (Hernandez-Hernandez et al., 2011). 236 
Cardelle-Cobas et al. (2011) when studying the effect of different trisaccharides isolated 237 
from GOS-Lu and GOS-La mixtures on different bacteria strains, including Lactobacillus, 238 
reported a preference for linkages β-(1-6) instead of β-(1-4); however, the results obtained 239 
in our work showed no differences in growth responses of Lactobacillus strains using GOS-240 
Lu or GOS-La.  241 
 242 
3.2.Lactic and acetic acid production 243 
 In general, for all strains and carbon sources tested, concentrations of lactic acid 244 
were higher than that of acetic acid (Table 1). Lactobacillus strains grown in glucose and 245 
lactulose generated higher concentrations of lactic acid than GOS-La and GOS-Lu, whilst 246 
similar levels of acetic acid were found for all assayed carbohydrates. The low amount of 247 
lactic acid produced in GOS grown culture could be due to the slower and prolonged 248 
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fermentation by the bacterial strains. This could also have an influence on the higher 249 
survival rate of Lactobacillus strains grown in GOS substrates (Figure 1), as a lower acid 250 
production leads to less acidic pH values. No significant differences were, in general, 251 
detected among the different incubation times either for each carbohydrate or between 252 
GOS-La and GOS-Lu. Lactic and acetic acids are fermentation products of lactic acid 253 
bacteria (Lindgren and Dobrogosz, 1990). These acids decrease the pH and consequently 254 
can prevent the over growth of pathogenic bacteria in the intestine (Roy et al., 2006). Short 255 
chain fatty acids (SCFA) such as acetic and lactic acids are involved in multiple beneficial 256 
effects on the host. Acetic acid is metabolised by different human tissues representing a 257 
route to obtain energy from non-digestible carbohydrates (Roy et al., 2006; Roberfroid et 258 
al., 2010); however, lactic and acetic acids are assimilated by different species present in 259 
the gut microbiota, producing butyric acid which can be involved in multiple positive 260 
effects such as the reduction of colon cancer risk (Roy et al., 2006; Falony et al. 2009; 261 
Roberfroid et al., 2010). 262 
 These results support that Lactobacillus strains are able to hydrolyze GOS 263 
synthesized from lactose and lactulose, as well as lactulose to produce beneficial 264 
metabolites as final products.    265 
 266 
3.3.Tolerance to different gastrointestinal conditions 267 
The survival responses of the Lactobacillus strains, previously grown in the 268 
different carbohydrates tested, after 1 and 3 hours of being exposed to different 269 
gastrointestinal conditions are shown in Tables 2 and 3.  270 
All the strains survived after 1 and 3 h of exposure to α-amylase and pancreatin 271 
treatments (Table 2), although a significant decrease in survival of LS incubated with 272 
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lactulose in the presence of amylase was observed. Survival rate values were greater than 273 
100 % in some cases which could be due to the presence of low molecular weight 274 
carbohydrates in the commercial enzymatic preparations. Pitino et al. (2010) reported an 275 
increase on the survival of some strains of L. rhamnosus during simulation of duodenal 276 
digestion, due to the presence of a carbon source in the MRS broth used as the vehicle for 277 
digestion of the cells. Similar data were found by Kimoto-Nira et al. (2009) for 278 
Lactococcus lactis in media containing bile salts and lactose as carbon source.  279 
Survival to bile extract appeared to be dependent on the carbon source and the 280 
Lactobacillus strain at both tested times (Table 3). After 1 hour a general decline in 281 
bacteria numbers was detected for all strains and carbon sources, with the exception of LB 282 
grown on glucose and lactulose and LP1 on lactulose. This decrease was greater at 3 hours 283 
of treatment. LC and LD exhibited the lowest survival rates for all carbohydrate sources, 284 
whereas LP1 was the most resistant strain.  285 
Regarding LB, its survival after bile treatment was higher when it was incubated 286 
with glucose and lactulose, whereas LC survived better when it was incubated with GOS-287 
Lu and GOS-La as compared to non-survival in the presence of glucose and lactulose after 288 
3 hours of fermentation. LD grown on lactulose exhibited its highest survival rate in the 289 
presence of the bile extract. Lower significant differences in bile tolerance were detected 290 
for LP1, LP2 and LS grown on the different carbohydrate sources.  291 
Charteris et al. (1998) reported that a level of survival higher than 30% would be 292 
considered intrinsically tolerant to gastric transit when using simulated gastric and 293 
pancreatic juices. Although the results presented here are based on resistance to bile 294 
extracts, this value could be considered to classify the Lactobacillus strains, tested for the 295 
different gastrointestinal conditions, as being as tolerant or not tolerant. Following this 296 
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premise, most of the strains grown in the different carbohydrates used could be considered 297 
as bile tolerant, with the exception of LC using glucose and lactulose. Similarly, Fernandez 298 
et al. (2003) and Koll et al. (2010) reported tolerance to bile salts at 0.15 and 2% w/v, 299 
respectively, of different Lactobacillus strains grown in MRS agar.  300 
Tolerance to gastric pH (2.5) expressed as % survival is shown in Table 3. In 301 
general, after 1 h of exposition, significant survival decreases were observed for all assayed 302 
strains. LB and LS grown on prebiotic carbohydrates exhibited a higher resistance to pH 303 
conditions than the strains grown on glucose, whereas LC and LD grown on glucose were 304 
more tolerant. LP1 and LP2 grown on lactulose or glucose exhibited higher resistance to 305 
low pH values. Although gastric emptying is strongly influenced by volume and 306 
composition of gastric contents, type of meal and/or gastrointestinal disorders (Bolondi et 307 
al., 1985), the average time for 50% of gastric emptying has been estimated to be 308 
approximately 1.2 hours (Read et al., 1986). This means that physiologically relevant levels 309 
of most of the studied Lactobacillus strains could be able to reach further down the 310 
gastrointestinal tract. Finally, at extreme exposure times to treatment (3 h), only LP2 grown 311 
on lactulose, GOS-La or GOS-Lu, LD grown on glucose and LS grown on GOS-Lu could 312 
be detected.  313 
 314 
3.4.Hydrophobicity of bacteria 315 
The percentage of hydrophobicity of all strains after 48h of fermentation is shown 316 
in Table 4. It is worth noting that LB, LC and LD grown with GOS-Lu exhibited the 317 
highest values of hydrophobicity, whereas hydrophobicity of LP1 and LS was higher when 318 
they were grown on GOS-La. Both prebiotic carbohydrates also contributed to the higher 319 
hydrophobicity values of LP2. Hydrophobic index of bacteria is related to their adhesion 320 
 15 
capacity to intestinal cells (Wadstrom et al., 1987). This capacity is necessary for the 321 
bacteria to colonize, at least temporally, the intestine and consequently, they may be 322 
considered as probiotics. Therefore, LB, LC and LD strains grown on GOS-Lu and LC, 323 
LP1 and LS strains grown on GOS-La could exhibit the higher adhesion capacity. It has 324 
also been reported that hydrophobicity index varies depending on the strain and the carbon 325 
source used (Kimoto-Nira et al., 2010) which is in good agreement with our results. 326 
      327 
In conclusion, resistance to gastrointestinal conditions (mainly to bile extracts and 328 
gastric pH values) and bacterial hydrophobicity depend highly on carbohydrates used as 329 
carbon source and the Lactobacillus strain. Growth of some Lactobacillus strains on 330 
different prebiotics could help to increase their resistance to gastrointestinal conditions, 331 
thus, enhancing their survival through the gastrointestinal tract, as well as to promote their 332 
adhesion capacity. Additionally, food matrix effects may also contribute to the ability of a 333 
probiotic to survive through the gastrointestinal tract (Sanders and Marco, 2010). Thus, 334 
several studies have previously shown that the inclusion of milk-based products improved 335 
the resistance to gastrointestinal conditions of different probiotics including some 336 
Lactobacillus strains (Charteris et al, 1998; Fernández et al, 2003; Madureira et al, 2010; 337 
Martinez et al, 2011). A possible explanation for this response is that milk proteins could 338 
act as buffering agents and/or inhibitors of digestive proteases (Charteris et al., 1998). On 339 
the basis of these studies, it could be expected that the combined use of milk-based 340 
products and GOS-La or GOS-Lu might increase the survival of the assayed Lactobacillus 341 
strains. These findings may help to expand the applications of lactulose, and 342 
galactooligosaccharides derived from lactulose and lactose in synbiotic products with 343 
important applications in the design of new functional food ingredients. 344 
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Table 1. Lactic acid and acetic acid concentrations (mM) after 24, 48 and 72 h of fermentation using glucose, lactulose, GOS from 1 
lactulose (GOS-Lu) and from lactose (GOS-La). LB (L. bulgaricus ATCC7517), LC (L. casei ATCC11578), LD (L. delbrueckii subsp. 2 
Lactis ATCC4797), LP1 (L. plantarum ATCC8014), LP2 (L. plantarum WCFS1), LS (L. sakei 23K). 3 
 4 
Carbon 
Source 
Acid Time (h) LB LC LD LP1 LP2 LS 
Glucose 
Lactic 
24 209.70 (0.20)*
efg
 178.54 (14.71)
efg
 203.52 (1.92)
efg
 184.33 (23.85)
efg
 203.18 (5.57)
efg
 189.12 (6.32)
efg
 
48 228.67 (27.53)
g
 197.93 (29.10)
efg
 203.09 (0.44)
efg
 184.55 (29.74)
efg
 208.12 (0.40)
efg
 192.89 (16.52)
efg
 
72 214.89 (5.69)
fg
 189.86 (23.11)
efg
 199.74 (0.40)
efg
 230.39 (41.87)
g
 199.79 (3.62)
efg
 198.20 (9.37)
efg
 
Acetic 
24 36.76 (2.89)
abcde
 34.34 (2.17)
abc
 33.61 (1.15)
abc
 32.68 (4.37)
ab
 32.82 (0.49)
ab
 37.37 (4.84)
abcde
 
48 42.65 (0.91)
abcde
 31.71 (1.34)
a
 31.97 (1.13)
a
 33.67 (3.10)
abc
 34.87 (0.22)
abc
 35.42 (0.44)
abcd
 
72 38.52 (3.94)
abcde
 31.04 (0.14)
a
 39.16 (14.93)
 abcde
 40.65 (8.53)
abcde
 31.35 (0.89)
a
 37.11 (2.68)
abcde
 
Lactulose 
Lactic 
24 180.67 (25.27)
 efg
 154.68 (3.47)
de
 165.38 (3.50)
efg
 199.46 (1.36)
efg
 201.05 (6.86)
efg
 158.91 (1.39)
def
 
48 215.54 (26.31)
fg
 208.51 (13.35)
efg
 203.18 (7.44)
efg
 204.92 (3.37)
efg
 206.51 (1.45)
efg
 195.12 (7.39)
efg
 
72 202.73 (10.70)
efg
 200.28 (3.02)
efg
 204.26 (0.51)
efg
 227.11 (36.28)
g
 203.36 (6.14)
efg
 202.85 (2.10)
efg
 
Acetic 
24 42.38 (0.90)
abcde
 38.39 (1.57)
abcde
 37.95 (1.93)
abcde
 49.11 (16.90)
abcde
 46.66 (1.25)
abcde
 48.70 (5.52)
abcde
 
48 49.46 (3.45)
abcde
 37.95 (4.93)
abcde
 32.41 (5.85)
ab
 42.19 (1.08)
abcde
 37.99 (6.26)
abcde
 45.07 (3.18)
abcde
 
72 42.96 (6.43)
abcde
 35.03 (2.19)
abc
 31.84 (0.56)
a
 48.42 (6.61)
abcde
 35.33 (3.20)
abcd
 44.12 (7.82)
abcde
 
GOS-Lu 
Lactic 
24 69.20 (1.52)
 abc
 183.87 (29.23)
efg
 42.90 (6.90)
ab
 63.61 (0.94)
abc
 66.72 (6.73)
abc
 67.42 (4.53)
abc
 
48 80.73 (4.40)
abc
 40.42 (2.05)
ab
 35.56 (9.37)
ab
 75.06 (5.23)
abc
 66.87 (6.21)
abc
 65.58 (6.10)
abc
 
72 77.09 (2.50)
abc
 43.80 (0.77)
ab
 44.51 (0.99)
ab
 87.71 (12.00)
abc
 67.30 (6.55)
abc
 71.26 (8.22)
abc
 
Acetic 
24 43.02 (5.75)
abcde
 42.49 (6.04)
abcde
 42.04 (0.94)
abcde
 63.07 (2.84)
e
 31.61 (2.12)
a
 58.52 (2.72)
bcde
 
48 54.13 (2.07)
abcde
 44.37 (2.05)
abcde
 43.64 (3.40)
abcde
 51.95 (0.09)
abcde
 44.42 (13.69)
abcde
 53.11 (0.12)
abcde
 
72 48.56 (10.26)
abcde
 42.32 (5.80)
abcde
 52.51 (13.54)
abcde
 59.21 (11.69)
cde
 42.42 (14.22)
abcde
 54.94 (2.83)
abcde
 
GOS-La 
Lactic 
24 65.66 (2.90)
 abc
 33.06 (11.05)
a
 54.12 (1.89)
abc
 46.91 (1.55)
abc
 76.81 (2.04)
abc
 77.96 (3.09)
abc
 
48 83.71 (9.03)
abc
 33.20 (10.09)
a
 36.14 (12.14)
ab
 102.97 (22.16)
cd
 82.53 (0.36)
abc
 80.25 (0.28)
abc
 
72 76.73 (7.55)
abc
 32.87 (9.92)
a
 33.52 (10.84)
a
 91.42 (16.87)
bc
 85.21 (2.95)
abc
 84.91 (1.25)
abc
 
Acetic 
24 45.22 (0.25)
abcde
 40.21 (12.37)
abcde
 46.47 (2.11)
abcde
 57.36 (1.97)
abcde
 61.59 (10.40)
de
 64.06 (3.85)
e
 
48 52.99 (2.45)
abcde
 47.05 (1.43)
abcde
 42.46 (1.66)
abcde
 59.38 (9.52)
cde
 52.35 (0.34)
abcde
 52.84 (1.89)
abcde
 
72 51.69 (0.32)
abcde
 47.69 (1.31)
abcde
 46.59 (2.88)
abcde
 57.10 (10.38)
abcde
 50.01 (1.82)
abcde
 53.46 (1.79)
abcde
 
 5 
*Standard deviation in parentheses 6 
Different letters indicate significant differences (P ≤ 0.05) for each acid7 
Table
Table 2. Survival (%) of strains grown in glucose, lactulose, GOS from lactulose (GOS-
Lu) and from lactose (GOS-La) in the presence of α-amylase and pancreatin after 1 and 3 
hours of fermentation. 
Strain % Survival 
Carbon source α-amylase 1h α-amylase 3h Pancreatin 1h  Pancreatin 3h 
      LB     
Glucose 95.74 (2.02)
§a
  99.53 (2.59)
a 
107.86 (2.95)
b*
 115.95 (2.95)
c* 
Lactulose 109.45 (1.97)
b* 
99.31 (3.54)
a 
119.96 (0.22)
cd*
 125.06 (14.91)
d* 
GOS-Lu 89.72 (0.84)
c
 98.23 (11.03)
a 
95.20 (2.82)
a
 114.45 (1.46)
c* 
GOS-La 105.55 (1.43)
b*
 104.90 (3.74)
b 
106.73 (3.82)
b*
 108.00 (3.41)
b* 
     
     LC     
Glucose 100.78 (6.59)
ab
  101.66 (6.48)
a 
108.66 (5.95)
b* 
104.60 (1.59)
abc 
Lactulose 96.58 (0.23)
a 
99.06 (2.12)
a 
106.53 (4.72)
b* 
105.58 (3.26)
bc* 
GOS-Lu 108.20 (4.61)
b*
 110.45 (2.46)
*b 
120.02 (6.26)
d*
 107.27 (6.98)
b* 
GOS-La 105.22 (12.03)
b*
 106.81 (10.80)
a 
103.56 (0.21)
abc 
100.54 (0.85)
ab 
     
     LD     
Glucose 105.66 (1.55)
c*
 107.70 (3.15)
c 
106.60 (2.23)
b*
 111.23 (0.28)
cd* 
Lactulose 103.99 (1.08)
b 
106.48 (2.56)
b 
106.71 (3.48)
bc*
 107.65 (0.68)
bc* 
GOS-Lu 93.91 (10.28)
a 
93.05 (10.62)
a 
105.81 (9.42)
bc*
 113.19 (2.63)
d* 
GOS-La 95.66 (5.18)
a 
93.77 (3.93)
a 
97.27 (3.54)
a
 108.46 (0.56)
bc* 
     
    LP1 
    
Glucose 99.00 (3.13)
a
 96.87 (2.47)
a 
91.33 (5.80)
b*
 91.28 (3.48)
a* 
Lactulose 106.43 (0.17)
bc*
 101.92 (0.22)
a 
97.99 (13.74)
ab
 99.73 (0.48)
a 
GOS-Lu 105.09 (0.00)
cd*
 97.80 (0.46)
a 
100.75 (6.74)
a 
101.05 (9.82)
a
 
GOS-La 106.98 (4.30)
d*
 100.77 (1.35)
a 
99.27 (4.05)
ab
 97.63 (6.64)
a 
     
    LP2     
Glucose 98.09 (4.42)
b
 92.63 (6.64)
a* 
97.01 (2.52)
a*
 95.82 (5.24)
c* 
Lactulose 102.64 (3.15)
c
 101.56 (3.08)
bc 
98.60 (1.06)
abcd
 98.00 (0.66)
acd 
GOS-Lu 100.15 (3.20)
bc
 100.72 (0.93)
bc
 99.00 (1.67)
abd
 101.02 (0.68)
b 
GOS-La 101.34 (4.10)
bc
 100.06 (3.09)
bc 
99.87 (2.55)
ab
 100.49 (1.53)
ab 
     
     LS     
Glucose 96.80 (0.98)
b 
99.86 (5.95)
b 
101.55 (3.13)
ab 
104.64 (0.57)
ab 
Lactulose 76.71 (0.87)
a* 
87.68 (4.92)
a 
100.16 (0.28)
a 
101.85 (0.40)
a 
GOS-Lu 108.21 (4.59)
c* 
101.90 (2.18)
b 
106.31 (4.40)
b* 
108.58 (5.16)
b* 
GOS-La 104.23 (6.56)
c 
100.18 (2.23)
b 
101.67 (7.82)
ab 
103.05 (6.00)
a 
 
§
Standard deviation in parentheses 
Different letters indicate significant differences (P ≤ 0.05) for each strain and treatment 
*Significant differences with 0 hours for each strain and treatment 
Table 3. Survival (%) of strains grown in glucose, lactulose, GOS from lactulose (GOS-
Lu) and from lactose (GOS-La) in the presence of bile extract and low pH after 1 and 3 
hours of fermentation. 
 
§
Standard deviation in parentheses 
Different letters indicate significant differences (P ≤ 0.05) for each strain and treatment 
*Significant differences with 0 hours for each strain and treatment 
ND no detected 
Strain % Survival 
Carbon source Bile extract 1h Bile extract 3h Low pH 1h  Low pH 3h 
     LB     
Glucose 100.50 (1.41)
§a 
96.94 (1.16)
a 
28.87 (1.16)
b*
 ND
 
Lactulose 98.36 (0.02)
a 
98.45 (2.83)
a 
72.90 (12.23)
a*
 ND 
GOS-Lu 78.41 (4.96)
d*
 43.19 (6.04)
b* 
74.61 (1.61)
a*
 ND 
GOS-La 87.95 (1.36)
e*§
 62.01 (0.82)
*c 
72.34 (0.86)
a*
 ND 
     
     LC     
Glucose 29.84 (5.77)
a*
 ND 29.85 (8.73)
a*
 ND 
Lactulose 30.97 (4.83)
a*
 ND 21.91 (3.44)
b*
 ND 
GOS-Lu 45.08 (6.69)
c*
 38.15 (4.27)
b* 
ND
 
 ND 
GOS-La 44.60 (4.57)
c*
 33.31 (0.85)
ab* 
ND ND 
     
     LD     
Glucose 55.84 (0.38)
b*
 38.78 (11.65)
a* 
60.63 (0.41)
d*
 28.03 (3.00)
e* 
Lactulose 72.93 (6.77)
d*
 63.45 (7.77)
c* 
42.05 (0.29)
b*
 ND 
GOS-Lu 37.63 (1.26)
a*
 35.88 (1.40)
a* 
55.21 (6.35)
c*
 ND 
GOS-La 52.02 (0.13)
b*
 33.22 (1.41)
a* 
37.94 (1.08)
a*
 ND 
     
    LP1 
    
Glucose 95.51 (3.69)
de*
 90.48 (2.30)
bc* 
77.58 (2.48)
a*
 ND 
Lactulose 99.69 (0.36)
a
 99.57 (0.36)
ae 
73.82 (3.41)
a*
 ND 
GOS-Lu 92.68 (6.73)
cd*
 90.07 (4.30)
bc* 
22.08 (0.01)
c*
 ND 
GOS-La 89.93 (4.46)
bc*
 87.66 (1.92)
b* 
25.76 (0.12)
b*
 ND 
     
    LP2     
Glucose 84.45 (2.04)
ab*
 77.81 (0.99)
c* 
69.56 (7.01)
f*
 ND 
Lactulose 85.29 (0.73)
ab*
 81.13 (1.04)
de* 
77.39 (5.92)
f*
 29.81 (2.42)
cd* 
GOS-Lu 85.96 (2.51)
b*
 79.14 (5.15)
cd* 
52.87 (2.36)
e*
 19.58 (0.13)
ab* 
GOS-La 82.45 (1.18)
ae*
 73.51 (4.04)
f* 
42.75 (13.00)
de*
 33.92 (0.79)
bc*
  
     
     LS     
Glucose 80.36 (3.32)
a*
 81.58 (7.00)
a* 
ND ND 
Lactulose 82.30 (1.37)
a*
 82.08 (2.82)
a* 
ND ND 
GOS-Lu 87.09 (3.56)
b*
 87.54 (1.38)
b* 
42.04 (0.22)
b* 
23.68 (0.03)
a* 
GOS-La 83.66 (0.23)
a*
 83.31 (1.69)
a* 
46.05 (5.46)
b*
 ND 
Table 4. Hydrophobicity (%) of strains grown in glucose, lactulose, GOS from lactulose 
(GOS-Lu) and from lactose (GOS-La). 
 % Hydrophobicity 
Carbon 
source 
LB LC LD LP1 LP2 LS 
Glucose 46.76 (8.40)
h§
 0.00 (0.00)
a
 0.00 (0.00)
a
 0.00 (0.00)
a
 0.00 (0.00)
a
 13.35 (1.29)
cd
 
Lactulose 0.00 (0.00)
a
 6.65 (1.44)
abc
 0.00 (0.00)
a
 0.00 (0.00)
a
 21.55 (8.91)
e
 29.76 (11.97)
f
 
GOS-Lu 64.05 (14.11)
i
 79.47 (6.47)
j
 80.09 (0.73)
j
 0.00 (0.00)
a
 28.75 (5.19)
f
 15.40 (5.29)
d
 
GOS-La 3.73 (0.17)
ab
 62.72 (1.50)
i
 0.00 (0.00)
a
 66.38 (4.45)
i
 27.90 (2.38)
f
 48.57 (2.76)
h
 
 
 
*Standard deviation 
§ Different letters indicate significant differences (P ≤ 0.05) for each acid 
VL: Vivinal-GOS purified and GOS: galactooligosaccharides from lactulose purified. 
 
 
 
Figure captions 
Figure 1. Growth of lactobacillus strains in MRS containing different carbohydrates carbon 
source. (♦) Glucose, (■) Lactulose, (▲) GOS from lactulose, (X) GOS from lactose. LB (L. 
bulgaricus ATCC7517), LC (L. casei ATCC11578), LD (L. delbrueckii subsp. Lactis 
ATCC4797), LP1 (L. plantarum ATCC8014), LP2 (L. plantarum WCFS1), LS (L. sakei 
23K). 
Figure
Figure 1. Hernandez-Hernandez et al. 
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